[Occupationally acquired MRSA colonization and occupational dermatological assessments (BK-No. 3101 in the German list of Occupational Diseases) : Analysis of the DGUV documentation and expert opinion on a case with work-related MRSA-triggered atopic dermatitis].
Beruflich erworbene MRSA-Besiedelung in der berufsdermatologischen Begutachtung (BK-Nr. 3101) : Auswertung der DGUV BK-Dokumentation und Gutachtenfall mit arbeitsbedingter MRSA-getriggerter atopischer Dermatitis.
Dermatitis, Atopic
Dermatitis, Occupational
/ diagnosis
Dermatology
/ standards
Documentation
Expert Testimony
Germany
/ epidemiology
Humans
Methicillin-Resistant Staphylococcus aureus
/ isolation & purification
Occupational Diseases
/ diagnosis
Practice Guidelines as Topic
Retrospective Studies
Staphylococcal Infections
/ diagnosis
Abnormal health condition
Asymptomatic MRSA colonization
Communicable disease
Occupation diseases
Occupational disease evaluation proceedings
Journal
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
ISSN: 1432-1173
Titre abrégé: Hautarzt
Pays: Germany
ID NLM: 0372755
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
pubmed:
5
6
2020
medline:
18
8
2020
entrez:
5
6
2020
Statut:
ppublish
Résumé
Person-to-person transmitted infectious diseases can cause occupational diseases (OD). These are subsumed as BK-No. 3101 in the German list of OD which applies for individuals with a considerably higher risk for infection as a consequence of their professional activity compared to the general population. The special medical and insurance law aspects of a work-related MRSA colonization are presented using the example of an expert opinion case and an evaluation of the BK reports of suspected occupational disease (BK No. 3101) of the German Social Accident Insurance (DGUV). The BK documentation of the DGUV from 2007-2012 and the patient cohort from the Department of Dermatology, University Hospital Erlangen, presenting for expert assessment from 2007-2012 were retrospectively analysed for human-to-human transmitted infectious diseases of the skin (BK-No. 3101). Person-to-person transmission of infectious diseases of the skin is rare in the field of occupational dermatology. In the DGUV cohort, suspected BK-No. 3101cases amounted to 2.6% of all notified cases; recognized BK-No. 3101 cases accounted for 4.2% of all recognized cases, amongst which 9 were caused by MRSA. In contrast to a symptomatic infection, an asymptomatic MRSA colonization is not being recognized as BK-No. 3101. Bacterial superantigens can trigger atopic dermatitis (AD). In particular cases, occupationally acquired MRSA can elicit AD and may justify classification as an OD (BK-No. 3101). Early detection of MRSA colonization and eradication are necessary for rehabilitation. Management of skin diseases due to infectious diseases within the framework of OD is presented.
Sections du résumé
BACKGROUND
BACKGROUND
Person-to-person transmitted infectious diseases can cause occupational diseases (OD). These are subsumed as BK-No. 3101 in the German list of OD which applies for individuals with a considerably higher risk for infection as a consequence of their professional activity compared to the general population.
OBJECTIVES
OBJECTIVE
The special medical and insurance law aspects of a work-related MRSA colonization are presented using the example of an expert opinion case and an evaluation of the BK reports of suspected occupational disease (BK No. 3101) of the German Social Accident Insurance (DGUV).
PATIENTS AND METHODS
METHODS
The BK documentation of the DGUV from 2007-2012 and the patient cohort from the Department of Dermatology, University Hospital Erlangen, presenting for expert assessment from 2007-2012 were retrospectively analysed for human-to-human transmitted infectious diseases of the skin (BK-No. 3101).
RESULTS
RESULTS
Person-to-person transmission of infectious diseases of the skin is rare in the field of occupational dermatology. In the DGUV cohort, suspected BK-No. 3101cases amounted to 2.6% of all notified cases; recognized BK-No. 3101 cases accounted for 4.2% of all recognized cases, amongst which 9 were caused by MRSA. In contrast to a symptomatic infection, an asymptomatic MRSA colonization is not being recognized as BK-No. 3101. Bacterial superantigens can trigger atopic dermatitis (AD). In particular cases, occupationally acquired MRSA can elicit AD and may justify classification as an OD (BK-No. 3101).
CONCLUSIONS
CONCLUSIONS
Early detection of MRSA colonization and eradication are necessary for rehabilitation. Management of skin diseases due to infectious diseases within the framework of OD is presented.
Identifiants
pubmed: 32494841
doi: 10.1007/s00105-020-04616-0
pii: 10.1007/s00105-020-04616-0
pmc: PMC7268186
doi:
Types de publication
Journal Article
Langues
ger
Sous-ensembles de citation
IM
Pagination
613-623Références
BMC Infect Dis. 2011 May 20;11:138
pubmed: 21599908
Indian J Dermatol Venereol Leprol. 2014 May-Jun;80(3):229-34
pubmed: 24823400
J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):396-9
pubmed: 25017526
J Dtsch Dermatol Ges. 2009 Jan;7 Suppl 1:S1-46
pubmed: 19138304
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Jun;57(6):696-732
pubmed: 24987771
Hautarzt. 2008 Aug;59(8):659-65; quiz 666
pubmed: 18636237
Chem Immunol Allergy. 2012;96:113-119
pubmed: 22433380
Lancet Infect Dis. 2008 May;8(5):289-301
pubmed: 18471774
Genome Res. 2012 May;22(5):850-9
pubmed: 22310478
Allergy. 2011 Mar;66(3):351-9
pubmed: 20831718
J Dtsch Dermatol Ges. 2015 Oct;13(10):1015-23
pubmed: 26408464
BMC Infect Dis. 2014 Jul 03;14:363
pubmed: 24996225
Med Klin Intensivmed Notfmed. 2017 Apr;112(3):186-191
pubmed: 28378152
Allergy. 2008 Jun;63(6):728-34
pubmed: 18445187
J Dtsch Dermatol Ges. 2012 Mar;10(3):186-96
pubmed: 22212172
J Occup Med Toxicol. 2013 May 27;8(1):16
pubmed: 23710905
Hautarzt. 2016 Jan;67(1):6-15
pubmed: 26016829
Allergy Asthma Immunol Res. 2019 Sep;11(5):593-603
pubmed: 31332972
Acta Derm Venereol Suppl (Stockh). 1989;144:50-4
pubmed: 2800907
Allergol Int. 2011 Mar;60(1):17-24
pubmed: 21252615
N Engl J Med. 2011 Oct 6;365(14):1315-27
pubmed: 21991953
J Clin Microbiol. 2008 Feb;46(2):456-61
pubmed: 18077648